fig3
Figure 3. Catumaxomab, is a chimeric antibody, consisting in a mouse-derived anti-EpCAM Fab (fragment antigen-binding) region and a rat-derived anti CD3 Fab
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/journal-cancer-metastasis-and-treatment
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
